The role of endoscopic therapy in obesity management: intragastric balloons and aspiration therapy

Nitin Kumar,1 Shelby Sullivan,2 Christopher C Thompson3 1Bariatric Endoscopy Institute, Addison, IL, 2Gastroenterology Bariatric and Metabolic Program, University of Colorado School of Medicine, Denver, CO, 3Gastroenterology and Therapeutic Endoscopy, Brigham and Women’s Hospital, Harvard...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Kumar N, Sullivan S, Thompson CC
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2017
Materias:	Intragastric balloon aspiration therapy Orbera Reshape Aspire AspireAssist Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/eba2a5da1fe44a2e9a271d5ae0596480
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:eba2a5da1fe44a2e9a271d5ae0596480
record_format	dspace
spelling	oai:doaj.org-article:eba2a5da1fe44a2e9a271d5ae05964802021-12-02T03:51:40ZThe role of endoscopic therapy in obesity management: intragastric balloons and aspiration therapy1178-7007https://doaj.org/article/eba2a5da1fe44a2e9a271d5ae05964802017-07-01T00:00:00Zhttps://www.dovepress.com/the-role-of-endoscopic-therapy-in-obesity-management-intragastric-ball-peer-reviewed-article-DMSOhttps://doaj.org/toc/1178-7007Nitin Kumar,1 Shelby Sullivan,2 Christopher C Thompson3 1Bariatric Endoscopy Institute, Addison, IL, 2Gastroenterology Bariatric and Metabolic Program, University of Colorado School of Medicine, Denver, CO, 3Gastroenterology and Therapeutic Endoscopy, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA Abstract: Weight management is increasingly incorporating endoscopic bariatric therapy (EBT). As the global burden of obesity and its comorbidities has increased, it is evident that novel therapeutic approaches will be necessary to address the obesity epidemic. EBTs offer greater efficacy than diet and lifestyle modification and lower invasiveness than bariatric surgery. The US Food and Drug Administration has approved two intragastric balloons and aspiration therapy for the treatment of obesity: Apollo Orbera is indicated for the treatment of Class I and Class II obesity, Re Shape Integrated Dual Balloon system is indicated for the same range with a comorbidity, and Aspire Bariatrics AspireAssist is approved for patients with a body mass index of 35–55 kg/m2. These devices have proven safe and effective in clinical trials and are gaining commercial acceptance in the USA; the Orbera has been used extensively outside the USA for over 20 years. These devices will need to be delivered in the context of a multidisciplinary weight loss program, integrating comprehensive care of obesity. Patient selection is important, and ensuring appropriate patient expectations and understanding of alternatives such as pharmacologic therapy and surgery is essential. With several EBTs on the horizon, patients with obesity will have an even broader array of safe and effective options for weight management in the future. Keywords: intragastric balloon, Orbera, ReShape, AspireAssist, aspiration therapy, weight lossKumar NSullivan SThompson CCDove Medical PressarticleIntragastric balloonaspiration therapyOrberaReshapeAspireAspireAssistSpecialties of internal medicineRC581-951ENDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol Volume 10, Pp 311-316 (2017)
institution	DOAJ
collection	DOAJ
language	EN
topic	Intragastric balloon aspiration therapy Orbera Reshape Aspire AspireAssist Specialties of internal medicine RC581-951
spellingShingle	Intragastric balloon aspiration therapy Orbera Reshape Aspire AspireAssist Specialties of internal medicine RC581-951 Kumar N Sullivan S Thompson CC The role of endoscopic therapy in obesity management: intragastric balloons and aspiration therapy
description	Nitin Kumar,1 Shelby Sullivan,2 Christopher C Thompson3 1Bariatric Endoscopy Institute, Addison, IL, 2Gastroenterology Bariatric and Metabolic Program, University of Colorado School of Medicine, Denver, CO, 3Gastroenterology and Therapeutic Endoscopy, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA Abstract: Weight management is increasingly incorporating endoscopic bariatric therapy (EBT). As the global burden of obesity and its comorbidities has increased, it is evident that novel therapeutic approaches will be necessary to address the obesity epidemic. EBTs offer greater efficacy than diet and lifestyle modification and lower invasiveness than bariatric surgery. The US Food and Drug Administration has approved two intragastric balloons and aspiration therapy for the treatment of obesity: Apollo Orbera is indicated for the treatment of Class I and Class II obesity, Re Shape Integrated Dual Balloon system is indicated for the same range with a comorbidity, and Aspire Bariatrics AspireAssist is approved for patients with a body mass index of 35–55 kg/m2. These devices have proven safe and effective in clinical trials and are gaining commercial acceptance in the USA; the Orbera has been used extensively outside the USA for over 20 years. These devices will need to be delivered in the context of a multidisciplinary weight loss program, integrating comprehensive care of obesity. Patient selection is important, and ensuring appropriate patient expectations and understanding of alternatives such as pharmacologic therapy and surgery is essential. With several EBTs on the horizon, patients with obesity will have an even broader array of safe and effective options for weight management in the future. Keywords: intragastric balloon, Orbera, ReShape, AspireAssist, aspiration therapy, weight loss
format	article
author	Kumar N Sullivan S Thompson CC
author_facet	Kumar N Sullivan S Thompson CC
author_sort	Kumar N
title	The role of endoscopic therapy in obesity management: intragastric balloons and aspiration therapy
title_short	The role of endoscopic therapy in obesity management: intragastric balloons and aspiration therapy
title_full	The role of endoscopic therapy in obesity management: intragastric balloons and aspiration therapy
title_fullStr	The role of endoscopic therapy in obesity management: intragastric balloons and aspiration therapy
title_full_unstemmed	The role of endoscopic therapy in obesity management: intragastric balloons and aspiration therapy
title_sort	role of endoscopic therapy in obesity management: intragastric balloons and aspiration therapy
publisher	Dove Medical Press
publishDate	2017
url	https://doaj.org/article/eba2a5da1fe44a2e9a271d5ae0596480
work_keys_str_mv	AT kumarn theroleofendoscopictherapyinobesitymanagementintragastricballoonsandaspirationtherapy AT sullivans theroleofendoscopictherapyinobesitymanagementintragastricballoonsandaspirationtherapy AT thompsoncc theroleofendoscopictherapyinobesitymanagementintragastricballoonsandaspirationtherapy AT kumarn roleofendoscopictherapyinobesitymanagementintragastricballoonsandaspirationtherapy AT sullivans roleofendoscopictherapyinobesitymanagementintragastricballoonsandaspirationtherapy AT thompsoncc roleofendoscopictherapyinobesitymanagementintragastricballoonsandaspirationtherapy
_version_	1718401619879526400

The role of endoscopic therapy in obesity management: intragastric balloons and aspiration therapy

Ejemplares similares